Nanjing Cellnuo Biotechnology Co.,Ltd.

Degludec insulin is a long-acting human insulin analogue that is expressed in Escherichia coli by recombinant DNA technology and then chemically modified. It is structurally comparable to human insulin: the threonine at B30 of non-human insulin is linked to a cetane fatty acid side chain via L-γ-glutamate ...

Tilposide is a novel dual receptor agonist of glucagon like peptide-1 receptor (GLP-1) and glucose dependent insulinotropic peptide (GIP), administered once a week. GLP-1 and GIP both belong to enterotropin, which is a peptide secreted by the human gastrointestinal mucosa. The former can bind to receptors ...

Good stability: conventional storage at ≤-20°C for one year results in little loss of activity, and after thawing, under aseptic conditions (2-8°C), there is little loss of activity for one month.Animal-free: produced by recombination, free of exogenous viral contamination, and no animal-derived raw materi...

In compliance with pharmacopoeia standards: in compliance with relevant standards for recombinant proteases in pharmacopoeias.No animal origin: produced by recombination, free of exogenous viral contamination, and no animal-derived materials are used in the production process.
Quality stability: mass pr...

Complies with regulatory requirements: We can produce high-purity and high-quality standard raw materials that meet GMP requirements. They can be used for scientific research and also exported as raw materials for formulation. For more information, please consult us.

Complete quality documents:...

Semaglutide API brochure of Cellnuo

Tirzepatide API brochure of Cellnuo

hEGF brochure of Cellnuo

Company profile and product list